Controlled Clinical Trials in Neurological Disease:
The evaluation of the efficacy and safety of a clinical tool, be it a diagnostic technique, a preventive methodology, or a therapeutic intervention, is an im portant responsibility of physicians. The history of medicine is characterized by the authoritarianisms of teachers and of organizations givi...
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Boston, MA
Springer US
1990
|
Schriftenreihe: | Foundations of Neurology
1 |
Schlagworte: | |
Online-Zugang: | UBR01 URL des Erstveröffentlichers |
Zusammenfassung: | The evaluation of the efficacy and safety of a clinical tool, be it a diagnostic technique, a preventive methodology, or a therapeutic intervention, is an im portant responsibility of physicians. The history of medicine is characterized by the authoritarianisms of teachers and of organizations giving way to the clinical experience of physicians; authoritarian dictum was replaced by case report and then by case series. As physicians learned to substitute the analysis of data for the inconsistencies of dictums and anecdotes, the problems of the case series as an investigative tool became more evident: patient selection criteria, measurements of outcome, significance of results, and extrapolation of conclusions to the community of patients. In response to these issues, the methodology of the controlled clinical trial has evolved and with it the instru ments of study design and of biostatistics as aids to study design and data analysis. The medical - surgical armamentarium has evolved from being dependent solely upon the observations and conclusions of a skilled clinician to being constructed upon the systematic collection and evaluation of data by a team of skilled clinicians and their statistical colleagues: this is the controlled clinical trial. During the past two decades, the evaluation of clinical approaches to pre vention and therapy has become particularly important to clinicians concerned with nervous system dysfunction. There has been and continues to be an explosion of information from the basic neurosciences and from the applica tion of biotechnology to the nervous system |
Beschreibung: | 1 Online-Ressource (XXIV, 440 p) |
ISBN: | 9781461314950 |
DOI: | 10.1007/978-1-4613-1495-0 |
Internformat
MARC
LEADER | 00000nmm a2200000zcb4500 | ||
---|---|---|---|
001 | BV046145620 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s1990 |||| o||u| ||||||eng d | ||
020 | |a 9781461314950 |9 978-1-4613-1495-0 | ||
024 | 7 | |a 10.1007/978-1-4613-1495-0 |2 doi | |
035 | |a (ZDB-2-SME)978-1-4613-1495-0 | ||
035 | |a (OCoLC)1118991463 | ||
035 | |a (DE-599)BVBBV046145620 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 616.8 |2 23 | |
245 | 1 | 0 | |a Controlled Clinical Trials in Neurological Disease |c edited by Roger J. Porter, Bruce S. Schoenberg |
264 | 1 | |a Boston, MA |b Springer US |c 1990 | |
300 | |a 1 Online-Ressource (XXIV, 440 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Foundations of Neurology |v 1 | |
520 | |a The evaluation of the efficacy and safety of a clinical tool, be it a diagnostic technique, a preventive methodology, or a therapeutic intervention, is an im portant responsibility of physicians. The history of medicine is characterized by the authoritarianisms of teachers and of organizations giving way to the clinical experience of physicians; authoritarian dictum was replaced by case report and then by case series. As physicians learned to substitute the analysis of data for the inconsistencies of dictums and anecdotes, the problems of the case series as an investigative tool became more evident: patient selection criteria, measurements of outcome, significance of results, and extrapolation of conclusions to the community of patients. In response to these issues, the methodology of the controlled clinical trial has evolved and with it the instru ments of study design and of biostatistics as aids to study design and data analysis. The medical - surgical armamentarium has evolved from being dependent solely upon the observations and conclusions of a skilled clinician to being constructed upon the systematic collection and evaluation of data by a team of skilled clinicians and their statistical colleagues: this is the controlled clinical trial. During the past two decades, the evaluation of clinical approaches to pre vention and therapy has become particularly important to clinicians concerned with nervous system dysfunction. There has been and continues to be an explosion of information from the basic neurosciences and from the applica tion of biotechnology to the nervous system | ||
650 | 4 | |a Neurology | |
650 | 4 | |a Neurosciences | |
650 | 4 | |a Neurology | |
650 | 4 | |a Neurosciences | |
650 | 0 | 7 | |a Kontrollierte klinische Studie |0 (DE-588)4202997-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Neurologie |0 (DE-588)4041888-1 |2 gnd |9 rswk-swf |
655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Neurologie |0 (DE-588)4041888-1 |D s |
689 | 0 | 1 | |a Kontrollierte klinische Studie |0 (DE-588)4202997-1 |D s |
689 | 0 | |8 2\p |5 DE-604 | |
700 | 1 | |a Porter, Roger J. |4 edt | |
700 | 1 | |a Schoenberg, Bruce S. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461288046 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780792306139 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461314967 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4613-1495-0 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031525805 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
966 | e | |u https://doi.org/10.1007/978-1-4613-1495-0 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180482522349568 |
---|---|
any_adam_object | |
author2 | Porter, Roger J. Schoenberg, Bruce S. |
author2_role | edt edt |
author2_variant | r j p rj rjp b s s bs bss |
author_facet | Porter, Roger J. Schoenberg, Bruce S. |
building | Verbundindex |
bvnumber | BV046145620 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-1-4613-1495-0 (OCoLC)1118991463 (DE-599)BVBBV046145620 |
dewey-full | 616.8 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.8 |
dewey-search | 616.8 |
dewey-sort | 3616.8 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-1-4613-1495-0 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03724nmm a2200553zcb4500</leader><controlfield tag="001">BV046145620</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1990 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461314950</subfield><subfield code="9">978-1-4613-1495-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4613-1495-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-4613-1495-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1118991463</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046145620</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.8</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Controlled Clinical Trials in Neurological Disease</subfield><subfield code="c">edited by Roger J. Porter, Bruce S. Schoenberg</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston, MA</subfield><subfield code="b">Springer US</subfield><subfield code="c">1990</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XXIV, 440 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Foundations of Neurology</subfield><subfield code="v">1</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The evaluation of the efficacy and safety of a clinical tool, be it a diagnostic technique, a preventive methodology, or a therapeutic intervention, is an im portant responsibility of physicians. The history of medicine is characterized by the authoritarianisms of teachers and of organizations giving way to the clinical experience of physicians; authoritarian dictum was replaced by case report and then by case series. As physicians learned to substitute the analysis of data for the inconsistencies of dictums and anecdotes, the problems of the case series as an investigative tool became more evident: patient selection criteria, measurements of outcome, significance of results, and extrapolation of conclusions to the community of patients. In response to these issues, the methodology of the controlled clinical trial has evolved and with it the instru ments of study design and of biostatistics as aids to study design and data analysis. The medical - surgical armamentarium has evolved from being dependent solely upon the observations and conclusions of a skilled clinician to being constructed upon the systematic collection and evaluation of data by a team of skilled clinicians and their statistical colleagues: this is the controlled clinical trial. During the past two decades, the evaluation of clinical approaches to pre vention and therapy has become particularly important to clinicians concerned with nervous system dysfunction. There has been and continues to be an explosion of information from the basic neurosciences and from the applica tion of biotechnology to the nervous system</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurosciences</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurosciences</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kontrollierte klinische Studie</subfield><subfield code="0">(DE-588)4202997-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Neurologie</subfield><subfield code="0">(DE-588)4041888-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Neurologie</subfield><subfield code="0">(DE-588)4041888-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Kontrollierte klinische Studie</subfield><subfield code="0">(DE-588)4202997-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Porter, Roger J.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schoenberg, Bruce S.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461288046</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780792306139</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461314967</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4613-1495-0</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031525805</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4613-1495-0</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV046145620 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:28Z |
institution | BVB |
isbn | 9781461314950 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031525805 |
oclc_num | 1118991463 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XXIV, 440 p) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 1990 |
publishDateSearch | 1990 |
publishDateSort | 1990 |
publisher | Springer US |
record_format | marc |
series2 | Foundations of Neurology |
spelling | Controlled Clinical Trials in Neurological Disease edited by Roger J. Porter, Bruce S. Schoenberg Boston, MA Springer US 1990 1 Online-Ressource (XXIV, 440 p) txt rdacontent c rdamedia cr rdacarrier Foundations of Neurology 1 The evaluation of the efficacy and safety of a clinical tool, be it a diagnostic technique, a preventive methodology, or a therapeutic intervention, is an im portant responsibility of physicians. The history of medicine is characterized by the authoritarianisms of teachers and of organizations giving way to the clinical experience of physicians; authoritarian dictum was replaced by case report and then by case series. As physicians learned to substitute the analysis of data for the inconsistencies of dictums and anecdotes, the problems of the case series as an investigative tool became more evident: patient selection criteria, measurements of outcome, significance of results, and extrapolation of conclusions to the community of patients. In response to these issues, the methodology of the controlled clinical trial has evolved and with it the instru ments of study design and of biostatistics as aids to study design and data analysis. The medical - surgical armamentarium has evolved from being dependent solely upon the observations and conclusions of a skilled clinician to being constructed upon the systematic collection and evaluation of data by a team of skilled clinicians and their statistical colleagues: this is the controlled clinical trial. During the past two decades, the evaluation of clinical approaches to pre vention and therapy has become particularly important to clinicians concerned with nervous system dysfunction. There has been and continues to be an explosion of information from the basic neurosciences and from the applica tion of biotechnology to the nervous system Neurology Neurosciences Kontrollierte klinische Studie (DE-588)4202997-1 gnd rswk-swf Neurologie (DE-588)4041888-1 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content Neurologie (DE-588)4041888-1 s Kontrollierte klinische Studie (DE-588)4202997-1 s 2\p DE-604 Porter, Roger J. edt Schoenberg, Bruce S. edt Erscheint auch als Druck-Ausgabe 9781461288046 Erscheint auch als Druck-Ausgabe 9780792306139 Erscheint auch als Druck-Ausgabe 9781461314967 https://doi.org/10.1007/978-1-4613-1495-0 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Controlled Clinical Trials in Neurological Disease Neurology Neurosciences Kontrollierte klinische Studie (DE-588)4202997-1 gnd Neurologie (DE-588)4041888-1 gnd |
subject_GND | (DE-588)4202997-1 (DE-588)4041888-1 (DE-588)4143413-4 |
title | Controlled Clinical Trials in Neurological Disease |
title_auth | Controlled Clinical Trials in Neurological Disease |
title_exact_search | Controlled Clinical Trials in Neurological Disease |
title_full | Controlled Clinical Trials in Neurological Disease edited by Roger J. Porter, Bruce S. Schoenberg |
title_fullStr | Controlled Clinical Trials in Neurological Disease edited by Roger J. Porter, Bruce S. Schoenberg |
title_full_unstemmed | Controlled Clinical Trials in Neurological Disease edited by Roger J. Porter, Bruce S. Schoenberg |
title_short | Controlled Clinical Trials in Neurological Disease |
title_sort | controlled clinical trials in neurological disease |
topic | Neurology Neurosciences Kontrollierte klinische Studie (DE-588)4202997-1 gnd Neurologie (DE-588)4041888-1 gnd |
topic_facet | Neurology Neurosciences Kontrollierte klinische Studie Neurologie Aufsatzsammlung |
url | https://doi.org/10.1007/978-1-4613-1495-0 |
work_keys_str_mv | AT porterrogerj controlledclinicaltrialsinneurologicaldisease AT schoenbergbruces controlledclinicaltrialsinneurologicaldisease |